0001104659-14-034700.txt : 20140505 0001104659-14-034700.hdr.sgml : 20140505 20140505174432 ACCESSION NUMBER: 0001104659-14-034700 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140427 FILED AS OF DATE: 20140505 DATE AS OF CHANGE: 20140505 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INCYTE CORP CENTRAL INDEX KEY: 0000879169 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 943136539 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ROUTE 141 & HENRY CLAY ROAD STREET 2: BUILDING E336 CITY: WILMINGTON STATE: DE ZIP: 19880 BUSINESS PHONE: 3024986700 MAIL ADDRESS: STREET 1: ROUTE 141 & HENRY CLAY ROAD STREET 2: BUILDING E336 CITY: WILMINGTON STATE: DE ZIP: 19880 FORMER COMPANY: FORMER CONFORMED NAME: INCYTE CORP DATE OF NAME CHANGE: 20030318 FORMER COMPANY: FORMER CONFORMED NAME: INCYTE GENOMICS INC DATE OF NAME CHANGE: 20000710 FORMER COMPANY: FORMER CONFORMED NAME: INCYTE PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930902 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Huber Reid M CENTRAL INDEX KEY: 0001607052 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12400 FILM NUMBER: 14814757 MAIL ADDRESS: STREET 1: C/O INCYTE CORPORATION, EXPERIMENTAL STN STREET 2: ROUTE 141 & HENRY CLAY ROAD, BLDG. E336 CITY: WILMINGTON STATE: DE ZIP: 19880 3 1 a3.xml 3 X0206 3 2014-04-27 0 0000879169 INCYTE CORP INCY 0001607052 Huber Reid M EXPERIMENTAL STATION, ROUTE 141 & HENRY CLAY ROAD WILMINGTON DE 19880 0 1 0 0 Exec VP & Chief Scientific Off Common Stock 16932 D Incentive Stock Option (right to buy) 5.46 2016-01-12 Common Stock 2900 D Incentive Stock Option (right to buy) 3.11 2016-01-26 Common Stock 7225 D Incentive Stock Option (right to buy) 9.41 2017-01-20 Common Stock 14329 D Incentive Stock Option (right to buy) 13.34 2017-05-17 Common Stock 1355 D Incentive Stock Option (right to buy) 14.72 2018-01-24 Common Stock 8030 D Incentive Stock Option (right to buy) 17.79 2019-01-18 Common Stock 6991 D Non-Qualified Stock Option (right to buy) 17.79 2019-01-18 Common Stock 16764 D Incentive Stock Option (right to buy) 18.32 2020-02-08 Common Stock 7458 D Non-Qualified Stock Option (right to buy) 18.32 2020-02-08 Common Stock 39208 D Incentive Stock Option (right to buy) 64.55 2021-01-20 Common Stock 1059 D Non-Qualified Stock Option (right to buy) 64.55 2021-01-20 Common Stock 21011 D Includes 16,309 shares underlying restricted stock units ("RSUs") that will vest in full on April 8, 2017, subject to Dr. Huber's continued service with the Issuer through such vesting date. The RSUs may be settled only for shares of common stock on a one-for-one basis. Beginning January 13, 2006, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years. Beginning January 27, 2009, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years. Beginning January 21, 2010, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years. Beginning May 18, 2010, options become exercisable in 25 installments, with the first 33.33% vesting January 21, 2011 and the remainder vesting monthly through January 21, 2013. Beginning January 25, 2011, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years. Beginning January 19, 2012, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years. Beginning February 9, 2013, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years. Beginning January 21, 2014, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years. /s/ Eric H. Siegel , Attorney-in-Fact 2014-05-05